Physician profile
Mark Noller
NPI 1497726095
$7,943.18
in general payments reported to CMS, 2019-2025
40 companies · $1,840 in 2025
The $1,840 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,123 · 2020: $566 · 2021: $592 · 2022: $1,305 · 2023: $1,301 · 2024: $1,215 · 2025: $1,840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,256 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,256.17 |
| Education | $100.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,824.40 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $1,590.55 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $523.99 | 2019-2025 | Erleada, Akeega, Balversa |
| Dendreon Pharmaceuticals LLC | $428.46 | 2019-2024 | Provenge |
| Amgen INC. | $375.58 | 2019-2023 | Xgeva |
| Urovant Sciences INC | $355.34 | 2021-2022 | |
| Abbvie INC. | $310.25 | 2019-2025 | |
| Antares Pharma, INC. | $306.98 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Coloplast Corp | $249.55 | 2019-2025 | Speedicath |
| Accord Healthcare, INC. | $198.13 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $187.26 | 2019-2025 | |
| Edap Technomed INC | $125.00 | 2023 | |
| Novartis Pharmaceuticals Corporation | $124.91 | 2024-2025 | |
| Blue Earth Diagnostics | $124.32 | 2022-2024 | |
| 180 Medical, INC. | $105.87 | 2020-2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $97.52 | 2020-2024 | Lynparza |
| Tolmar Pharmaceuticals, INC. | $83.24 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $78.42 | 2022-2025 | Pylarify |
| Pfizer INC. | $78.21 | 2019-2025 | |
| Immunitybio, INC. | $63.34 | 2024 | |
| Verity Pharmaceuticals INC. | $62.73 | 2025 | Tlando |
| Therapeuticsmd, INC. | $62.43 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $52.11 | 2022-2023 | Prolaris |
| Endo Pharmaceuticals INC. | $49.25 | 2019-2023 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $48.13 | 2021-2022 | |
| Telix Pharmaceuticals | $46.26 | 2025 | Illuccix |
| Allergan, INC. | $46.22 | 2021-2022 | |
| Hollister Incorporated | $41.43 | 2022 | |
| Ferring Pharmaceuticals INC. | $40.96 | 2019-2025 | Adstiladrin |
| Ethicon US, LLC | $38.42 | 2023 | Vistaseal |
| Photocure INC | $33.56 | 2019-2020 | |
| Olympus America INC. | $30.03 | 2024 | Itind System |
| Tolmar, INC. | $28.38 | 2023 | |
| Laborie Medical Technologies Corp. | $26.08 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Myovant Sciences INC. | $19.94 | 2022 | |
| Procept Biorobotics Corporation | $19.25 | 2019 | |
| Dentsply Ih INC. | $18.19 | 2020 | |
| Axonics, INC. | $17.00 | 2021 | |
| Halozyme INC | $15.96 | 2023 | |
| Zyla Life Sciences, INC. | $15.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Noller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.